Read more about the featured scientists (in order of appearance):

Aaron Mandell, Co-founder, and Chairman, WaterFX - Aaron Mandell has co-founded six companies at the nexus of energy and water, including AltarockWaterFXQuidnetOasys Water, Coskata, and GreatPoint. Through his leadership, this portfolio is advancing new products in fields such as enhanced geothermal energy, solar water treatment, desalination, energy storage, coal gasification" data-wsc-lang="en_US">gasification, and alternative chemicals.

Sandra Postel, Director, Global Water Policy Project - Sandra Postel directs the independent Global Water Policy Project, and lectures, writes and consults on global water issues. In 2010 she was appointed Freshwater Fellow of the National Geographic Society, where she serves as the Society’s lead freshwater expert.  Sandra is co-creator of Change the Course, the national freshwater conservation and restoration campaign being pioneered by National Geographic and its partners and piloted in the Colorado River Basin.

Dr. Maria Croyle, Ph.D., Professor of Pharmaceutics, The University of Texas at Austin - Dr. Croyle recently developed a needle-free vaccine for the Ebola virus that has been proven 100% effective in primates. Her expertise has been recognized at the national and international levels as she has served as a scientific advisor for over 14 biotech companies located in the United States and Europe.

Laura Deming, Partner, The Longevity Fund - Laura Deming began lab work at UCSF at 12, went to MIT at 14, and at 17 received a Thiel Fellowship and started a business. Currently, she is one of the youngest venture capitalists in the industry, running The Longevity Fund, with a portfolio of companies dedicated to tackling aging and age-related diseases.

Dr. Brian Kennedy. President & CEO, Buck Institute for Research on Aging - Dr. Brian Kennedy is internationally recognized for his research in the basic biology of aging and as a visionary committed to translating research discoveries into new ways of delaying, detecting, preventing and treating age-related conditions. These include Alzheimer’s and Parkinson’s disease, cancer, stroke, macular degeneration, osteoporosis, diabetes, and heart disease among others.

Trish Aekler, Program Manager, Exoskeleton Technologies, Lockheed Martin - Trish Aelker is the program manager for Exoskeleton Technologies at Lockheed Martin. Aelker helped to develop Lockheed’s FORTIS technology – an exoskeleton suit that allows laborers to operate heavy machinery for long periods of time. Aelker has over 15 years of experience working Department of Defense programs.

Alzheimer's disease
Noun

brain disease characterized by confusion, disorientation, and memory failure.

biotechnology
Noun

the use of a living organism for industrial or medical use.

cancer
Noun

growth of abnormal cells in the body.

desalination
Noun

process of converting seawater to fresh water by removing salt and minerals.

diabetes
Noun

disease where the body is unable to produce or regulate certain types of carbohydrates.

exoskeleton
Noun

the hard external shell or covering of some animals.

failure
Noun

lack of success.

freshwater
Noun

water that is not salty.

gasification
Noun

process that converts solid or liquid carbon-based material into the gases carbon monoxide, hydrogen, and carbon dioxide.

Noun

heat energy generated within the Earth.

heart disease
Noun

illness affecting the heart and circulatory system.

perseverance
Noun

consistent effort despite any setback.

persist
Verb

to endure or continue.

primate
Noun

type of mammal, including humans, apes, and monkeys.

stroke
Noun

injury caused by a blood clot in the brain.

vaccine
Noun
preparation of a weakened or killed pathogen, or of a portion of the pathogen's structure that upon administration stimulates antibody production against the pathogen but is incapable of causing severe infection itself.
venture capital
Noun

funds provided for a new business by individuals or organizations other than those who own the business.